appScorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
News & Opinions
Torrent Pharma’s Gujarat facility gets one USFDA observation
1 week ago•Business Standard
Tata Consumer, Navin Fluorine, Torrent Pharma, Havells India in focus
1 week ago•Business Standard
USFDA issues Form-483 with one observation to Torrent Pharma’s Gujarat plant
1 week ago•Moneycontrol
Buy Torrent Pharmaceuticals; target of Rs 1788: Sharekhan
1 week ago•Moneycontrol
IRCTC, Bosch, Cochin Shipyard, Balrampur Chini, Torrent Pharma to turn ex-dividend; IRB Infra stock split & more
1 month ago•Business Today
Torrent Pharmaceuticals forays into OTC segment with calcium supplement
1 month ago•Business Standard
Torrent Pharma forays into OTC segment with calcium supplement
1 month ago•Economic Times